New online tool to manage medical device reimbursement across Europe

NewsGuard 100/100 Score

Factory-CRO announced that it has launched a Web-based tool for medical device companies that wish to market and sell products in Europe.

The website, http://www.factory-reimbursement.com, contains specific regulatory guidance on how to secure insurance reimbursement for medical devices companies in 17 European countries.

European reimbursement of medical devices has been a formidable obstacle for many manufacturers and marketers because the process varies not only from country to country, but sometimes even within different regions of the same country.

The website features three primary sections: An online database of reimbursement and regulatory data by country; a catalog of country-specific Reimbursement Reports; and access to Factory's team of expert consultants.

“For the first time ever, medical device companies can quickly understand the various processes for reimbursement across Europe,” says Joris Bannenberg, COO of Factory-CRO. “The online database simplifies this otherwise very confusing situation.” Yet, the website contains detailed data aggregated from Austria, Belgium, Denmark, Finland, France, Germany, Italy, Norway, Poland, Spain, Sweden, Switzerland, The Czech Republic, The Netherlands, and The United Kingdom. The number of countries will be soon extended in order to cover all European countries. “Quick access to this detailed regulatory data and reimbursement timelines will help any medical device manufacturer plan a more efficient entry into Europe,” adds Bannenberg.

Also available through the new website are detailed country-specific Reimbursement Reports. Each report contains detailed information about one country that supports both reimbursement and marketing strategies for medical devices. All Reimbursement Reports are kept thoroughly up-to-date by Factory's expert staff.

Formerly known as the Jacoti reports, the Factory team has brought these highly-respected reports completely up to date. Factory-Reimbursement is the only place you will find the original Jacoti reports, and the best place for the most current information.

Factory-CRO is a recognized leader in providing clinical research to the Medical Device industry. The new web offering showcases the tremendous strategic value that Factory-CRO brings to its clientele. Factory-CRO is represented in the USA by AmeriStart of Charlotte, NC who has a medical device sales associate able to answer questions.

About Factory-CRO

Based in The Netherlands, Factory-CRO is a full service European Contract Research Organization specializing in medical device trials. Factory-CRO has more than 20 years experience in clinical research, including biological studies and device-drug combination with a focus on orthopedic devices and wound healing. Factory-CRO operates in more than 20 countries, and provides in-person technical training for Investigators in the field. Find details at www.factory-cro.com.

About AmeriStart

From headquarters in Charlotte, NC, AmeriStart represents a portfolio of world-class service providers to the Life Science industry. Details are available at www.AmeriStart.com. For more information, contact David Worrell at 803-831-1880 x227 or [email protected].

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis